Literature DB >> 12743813

Proliferative activities of tumor stromal cells play important roles in tumor thickness and progression of T3 ulcerative-type colorectal cancer.

Takahiro Hasebe1, Satoshi Sasaki, Masanori Sugitoh, Masato Ono, Norio Saitoh, Atsushi Ochiai.   

Abstract

The central depressed area thickness (tumor thickness) of colorectal cancers is an important prognostic parameter for colorectal cancer patients. We examined whether the proliferative activities of tumor and stromal components play important roles in the increase of tumor thickness and the progression of colorectal cancers. Colorectal cancers were classified into thin and thick groups according to tumor thickness. The proliferative activities of fibroblasts and endothelial cells were immunohistochemically evaluated in 157 T3 ulcerative-type colorectal cancers by CD31/MIB-1 (anti-Ki-67 antigen) double staining. The MIB-1 labeling index was estimated as the percentage of fibroblasts with positive nuclei. The CD31-positive microvessels lined by MIB-1-positive endothelial cells were assessed. The proliferative microvessel index was defined as the percentage of proliferative microvessels relative to all microvessels. The fibroblast MIB-1 labeling index was the only parameter significantly associated with tumor thickness ( P=0.049). High fibroblast MIB-1 labeling indices showed significant correlation with tumor recurrence in the thin group ( P=0.020). High proliferative microvessel index was a significant parameter of tumor recurrence in the thick group ( P=0.003) in multivariate analyses. This study strongly suggests that proliferative activities of stromal components are useful parameters of tumor biology and of prognosis for T3 ulcerative-type colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743813     DOI: 10.1007/s00428-003-0811-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast.

Authors:  T Hasebe; S Sasaki; S Imoto; A Ochiai
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.

Authors:  D V Parums; J L Cordell; K Micklem; A R Heryet; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

3.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis.

Authors:  P Nangia-Makker; Y Honjo; R Sarvis; S Akahani; V Hogan; K J Pienta; A Raz
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Stromal and vascular invasion in an human in vitro bladder cancer model.

Authors:  C Booth; P Harnden; L K Trejdosiewicz; S Scriven; P J Selby; J Southgate
Journal:  Lab Invest       Date:  1997-06       Impact factor: 5.662

5.  Transrectal ultrasonography of rectal carcinoma.

Authors:  D D Dershaw; W E Enker; A M Cohen; E R Sigurdson
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

6.  Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.

Authors:  C Hornig; B Barleon; S Ahmad; P Vuorela; A Ahmed; H A Weich
Journal:  Lab Invest       Date:  2000-04       Impact factor: 5.662

7.  Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.

Authors:  J A Uría; M Ståhle-Bäckdahl; M Seiki; A Fueyo; C López-Otín
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

8.  Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer.

Authors:  T Hasebe; S Sasaki; M Sugitoh; M Ono; N Saitoh; A Ochiai
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

9.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  3 in total

1.  Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.

Authors:  Samuel R Denmeade; Annastasiah M Mhaka; D Marc Rosen; W Nathaniel Brennen; Susan Dalrymple; Ingrid Dach; Claus Olesen; Bora Gurel; Angelo M Demarzo; George Wilding; Michael A Carducci; Craig A Dionne; Jesper V Møller; Poul Nissen; S Brøgger Christensen; John T Isaacs
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

2.  Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.

Authors:  W Nathaniel Brennen; D Marc Rosen; Hao Wang; John T Isaacs; Samuel R Denmeade
Journal:  J Natl Cancer Inst       Date:  2012-08-21       Impact factor: 13.506

Review 3.  Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis.

Authors:  Yibaina Wang; Xiaoping Yao; Jie Ge; Fulan Hu; Yashuang Zhao
Journal:  ScientificWorldJournal       Date:  2014-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.